A Devastating New Exposé of Johnson & Johnson Indicts an Entire System

A Devastating New Exposé of Johnson & Johnson Indicts an Entire System

An investigative history of the scandal-plagued company shines a light on a health care industry riddled with corruption and criminality.

European Commission approves Johnson & Johnson’s Crohn’s disease therapy - Pharmafile

The European Commission (EC) has granted Marketing Authorisation (MA) to Johnson & Johnson’s Tremfya (guselkumab) for the treatment of moderately to severely active Crohn’s disease (CD) in adults. The decision follows positive results from two phase 3 programmes, GALAXI and GRAVITI, demonstrating guselkumab’s efficacy and safety. Guselkumab became the first approved fully human, dual acting IL-23p19 […] The post European Commission approves John…